151 related articles for article (PubMed ID: 37133568)
1. ASO Author Reflections: The Clinical Relevance of Sentinel Nodes in Minor Lymph Node Fields Such as the Triangular Intermuscular Space in Patients with Melanoma.
Schoenfeldt T; Chakera AH; Nieweg OE; Thompson JF
Ann Surg Oncol; 2023 Sep; 30(9):5770-5771. PubMed ID: 37133568
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Comparison of Indocyanine Green with Blue Dye in Sentinel Lymph Node Biopsy for Cutaneous Melanoma.
Fadel MG; Smith MJ
Ann Surg Oncol; 2023 Jul; 30(7):4341-4342. PubMed ID: 37014554
[No Abstract] [Full Text] [Related]
3. Sentinel Lymph Node Biopsy for Melanoma: Buggy Whip or Roller Bearing?
Karakousis GC; Faries MB
Ann Surg Oncol; 2020 Aug; 27(8):2586-2588. PubMed ID: 32519145
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Risk Stratification of Sentinel Node Metastases in Stage III Melanoma Patients in the Era of Adjuvant Systemic Therapy.
Hussain Z; Moncrieff M
Ann Surg Oncol; 2023 Mar; 30(3):1820-1821. PubMed ID: 36539582
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Role of Sentinel Lymph Node Biopsy in T1b Melanoma.
Hu Y; Brady MS
Ann Surg Oncol; 2020 Dec; 27(13):5257-5258. PubMed ID: 32529270
[No Abstract] [Full Text] [Related]
6. A commentary on "Does the time interval between sentinel lymph node biopsy and completion lymph node dissection affect outcome in malignant melanoma? A retrospective cohort study" - correspondence.
Saravanan M; Arockiaraj J; Belete MA
Int J Surg; 2024 Mar; 110(3):1862-1863. PubMed ID: 38116653
[No Abstract] [Full Text] [Related]
7. RE: A Clinical Decision Tool to Calculate Pretest Probability of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma.
Prieto PA; Goldberg MS; Martin B
Ann Surg Oncol; 2023 Oct; 30(11):6357-6358. PubMed ID: 37400617
[No Abstract] [Full Text] [Related]
8. ASO Author Reflections: Adjuvant Therapy is Effective for Melanoma Patients with Positive Sentinel Lymph Node Biopsy Who Forgo Completion Lymphadenectomy.
Farrow NE; Beasley GM
Ann Surg Oncol; 2020 Dec; 27(13):5126-5127. PubMed ID: 32409964
[No Abstract] [Full Text] [Related]
9. ASO Author Reflections: Management of the Lymph Node Basin in Cutaneous Melanoma-Patterns of Completion Dissection in a National Cohort.
Sharon CE; Karakousis GC; Miura JT
Ann Surg Oncol; 2022 Dec; 29(13):8465-8466. PubMed ID: 35933534
[No Abstract] [Full Text] [Related]
10. Underuse of sentinel lymph node biopsy for early-stage melanoma.
Rajeh A; Wan G; Roster K; Rashdan H; Seo J; Nguyen N; Collier MR; Leung BW; Semenov YR
J Am Acad Dermatol; 2023 Oct; 89(4):803-806. PubMed ID: 37244413
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Recurrence in Sentinel Node-Positive Node Fields in Melanoma Patients Undergoing Surveillance Is More Common outside the Node Field.
Gjorup CA; van Akkooi ACJ
Ann Surg Oncol; 2024 Mar; 31(3):1880-1881. PubMed ID: 38044350
[No Abstract] [Full Text] [Related]
12. Re: "Time to reconsider the role of sentinel lymph node biopsy in melanoma".
Faries MB; Cochran AJ; Thompson JF
J Am Acad Dermatol; 2023 Jan; 88(1):e25-e26. PubMed ID: 30928469
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: The Impacts of a Negative Sentinel Lymph Node on Quality of Life.
Banting S; Gyorki DE
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):651-652. PubMed ID: 31228135
[No Abstract] [Full Text] [Related]
14. Local recurrence in patients undergoing wide excision and sentinel lymph node biopsy for cutaneous malignant melanoma: A single-center, retrospective cohort analysis.
Straker RJ; Kelly N; Sharon CE; Shannon AB; Xu X; Elder DE; Chu EY; Miura JT; Karakousis GC
J Am Acad Dermatol; 2022 Jul; 87(1):247-250. PubMed ID: 34391811
[No Abstract] [Full Text] [Related]
15. Assessing rates of compliance with national guidelines regarding sentinel lymph node biopsy for invasive melanomas treated with Mohs surgery.
Cheraghlou S; Doudican NA; Criscito MC; Stevenson ML; Carucci JA
J Am Acad Dermatol; 2022 Dec; 87(6):1422-1425. PubMed ID: 35987400
[No Abstract] [Full Text] [Related]
16. ASO Author Reflections: Sentinel Lymph Node Biopsy is Prognostic in the Thickest Melanoma Cases and Should be Performed for Thick Melanomas.
Morrison S; Han D
Ann Surg Oncol; 2021 Feb; 28(2):1017-1018. PubMed ID: 32533399
[No Abstract] [Full Text] [Related]
17. ASO Author Reflections: Near Infrared (NIR) Fluorescence is Not a Substitute for Lymphoscintigraphy and Gamma Probe for Melanoma Sentinel Node Detection: Results from a Prospective Trial.
Vazquez VL
Ann Surg Oncol; 2020 Aug; 27(8):2913-2914. PubMed ID: 32240441
[No Abstract] [Full Text] [Related]
18. Completion Node Dissection for Sentinel Node-Positive Melanoma: Can a Systematic Review Bring One Discussion to a Close While Leaving the Broader Conversation Still Open?
Berman RS; Gershenwald JE
Ann Surg Oncol; 2019 Apr; 26(4):921-923. PubMed ID: 30737667
[No Abstract] [Full Text] [Related]
19. ASO Author Reflections: Standardizing Pathology Examination of Sentinel Lymph Nodes in Invasive Lobular Carcinoma: Less Is More.
Hieken TJ; Solanki MH
Ann Surg Oncol; 2022 Oct; 29(10):6466-6467. PubMed ID: 35930110
[No Abstract] [Full Text] [Related]
20. New Zealand patients have a higher melanoma burden in sentinel nodes and completion lymphadenectomy than patients in MSLT-II.
Williams TS; Arahill-Whitham J; Bailey TA; Hayward G; Li A; Tallon B; Wen D; Adams BM
J Plast Reconstr Aesthet Surg; 2023 Aug; 83():98-105. PubMed ID: 37271003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
